MICROBOT MEDICAL INC.

NASDAQ:MBOT
Annual Meeting

of Shareholders

MEETING DATE

12/14/2026
DEF 14A FILED
11/02/2026
PUBLISHED
11/03/2026 1:30 pm
TIME TO PUBLISH
11/05/2026
METHODOLOGY
approve
EXCHANGE NASDAQ:MBOT · CUSIP 59503A204 · CLASS common stock, $.01 par value · CIK 0000883975

RECONCILED · MIXED

Reconciled against the company’s Form 8-K Item 5.07 filed 2026-06-15.

4
FOR
0
AGAINST
0
WITHHOLD
4
BALLOT ITEMS

ITEM-BY-ITEM RECOMMENDATIONS

1
The election of two Class II directors to the Board of Directors of the Company to serve until the 2029 Annual Meeting of Shareholders
board
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

Corporate Governance Committee recommended and the Board nominated Scott Burell and Aileen Stockburger.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
2
The approval of a non-binding advisory resolution supporting the compensation of the Company’s named executive officers
compensation
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

Board states the Compensation Committee will consider the vote outcome in future compensation decisions.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
3
An amendment to the Microbot Medical Inc. 2020 Omnibus Performance Award Plan to increase the number of authorized shares of common stock reserved for issuance by 1,000,000 shares
compensation
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

Amendment only increases authorized shares by 1,000,000 and changes no other plan provisions.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
4
Ratification of Brightman Almagor Zohar & Co., a Member of Deloitte Touche Tohmatsu Limited, or its U.S. affiliate, as the Company’s independent registered public accounting firm for the year ending December 31, 2026
auditor
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

Audit Committee concluded the services provided are compatible with auditor independence.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.

Ledger

795816ab1a22f893b5d1bb7221bfa82de6377ad948b5534ffc33212ff249edf3

Search company, ticker, executive, director or issue

    The SPI Wire · Proxy Intelligence

    Get every ballot call, before the vote.

    FOR, AGAINST or WITHHOLD on each covered ballot item — published within 48 hours of the definitive proxy filing. Follow the companies you own, or take the full feed.




    Pick the companies you own — you’ll only hear from us on their ballots.

    The SPI Wire covers proxy ballots only — it has nothing to do with Signal Research investigations. Research and analysis for informational purposes; not legal, investment, or voting advice. Unsubscribe anytime.

    Submit Information








      Join Monitoring List




        Receive Research Updates